Because approximately 10% of clinically diagnosed patients with HHT have unidentified mutations, the study of intronic sequences, splice sites, and promoter regions of both the ACVRL1 and ENG genes is critical importance. Here, ACVRL1 is linked to hereditary hemorrhagic telangiectasia.